These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24350418)

  • 21. Health-related quality of life in psoriasis: an analysis of Psocare project patients.
    Spandonaro F; Altomare G; Berardesca E; Calzavara-Pinton P; Chimenti S; Girolomoni G; Peserico A; Guerra AP; Vena GA; Polistena B; Ayala F
    G Ital Dermatol Venereol; 2011 Jun; 146(3):169-77. PubMed ID: 21566546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis.
    Sampogna F; Chren MM; Melchi CF; Pasquini P; Tabolli S; Abeni D;
    Br J Dermatol; 2006 Feb; 154(2):325-31. PubMed ID: 16433804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics of Thai patients with psoriasis.
    Jiamton S; Suthipinittharm P; Kulthanan K; Chularojanamontri L; Wongpraparut C; Silpa-archa N; Sirikudta W
    J Med Assoc Thai; 2012 Jun; 95(6):795-801. PubMed ID: 22774624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained improvement of the quality of life of patients with psoriasis after hospitalization.
    Vensel E; Hilley T; Trent J; Taylor JR; Kirsner RS; Kerdel FA; Taylor JR; Schwartzberg JB
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):858-60. PubMed ID: 11050595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psoriasis: correlation between severity index (PASI) and quality of life index (DLQI) in patients assessed before and after systemic treatment.
    Silva MF; Fortes MR; Miot LD; Marques SA
    An Bras Dermatol; 2013; 88(5):760-3. PubMed ID: 24173182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life in persons living with psoriasis patients.
    Martínez-García E; Arias-Santiago S; Valenzuela-Salas I; Garrido-Colmenero C; García-Mellado V; Buendía-Eisman A
    J Am Acad Dermatol; 2014 Aug; 71(2):302-7. PubMed ID: 24836080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial.
    Lebwohl M; Papp K; Han C; Schenkel B; Yeilding N; Wang Y; Krueger GG
    Br J Dermatol; 2010 Jan; 162(1):137-46. PubMed ID: 19903183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of patient-reported outcomes in moderate to severe psoriasis.
    Krenzer S; Radtke M; Schmitt-Rau K; Augustin M
    Dermatology; 2011; 223(1):80-6. PubMed ID: 21876341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions.
    Rencz F; Poór AK; Péntek M; Holló P; Kárpáti S; Gulácsi L; Szegedi A; Remenyik É; Hidvégi B; Herszényi K; Jókai H; Beretzky Z; Brodszky V
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):783-790. PubMed ID: 29114942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic stress experience and burnout syndrome have appreciable influence on health-related quality of life in patients with psoriasis.
    Breuer K; Göldner FM; Jäger B; Werfel T; Schmid-Ott G
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1898-904. PubMed ID: 25732784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life and clinical features in Swedish children with psoriasis.
    Gånemo A; Wahlgren CF; Svensson Å
    Pediatr Dermatol; 2011; 28(4):375-9. PubMed ID: 21736605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive effect of modified Goeckerman regimen on quality of life and psychosocial distress in moderate and severe psoriasis.
    Chern E; Yau D; Ho JC; Wu WM; Wang CY; Chang HW; Cheng YW
    Acta Derm Venereol; 2011 Jun; 91(4):447-51. PubMed ID: 21537818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis.
    Balato N; Megna M; Di Costanzo L; Balato A; Ayala F
    Br J Dermatol; 2013 Jan; 168(1):201-5. PubMed ID: 23240729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.
    Feldman SR; Gordon KB; Bala M; Evans R; Li S; Dooley LT; Guzzo C; Patel K; Menter A; Gottlieb AB
    Br J Dermatol; 2005 May; 152(5):954-60. PubMed ID: 15888152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dramatic impact of a Psoriasis Area and Severity Index 90 response on the quality of life in patients with psoriasis: an analysis of Japanese clinical trials of infliximab.
    Torii H; Sato N; Yoshinari T; Nakagawa H;
    J Dermatol; 2012 Mar; 39(3):253-9. PubMed ID: 22211581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ustekinumab improves health-related quality of life in Korean and Taiwanese patients with moderate to severe psoriasis: results from the PEARL trial.
    Tsai TF; Song M; Shen YK; Schenkel B; Choe YB; Kim NI; Lee JH; Lee JH; Song HJ; Youn JI;
    J Drugs Dermatol; 2012 Aug; 11(8):943-9. PubMed ID: 22859239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologics are more potent than other treatment modalities for improvement of quality of life in psoriasis patients.
    Takahashi H; Iinuma S; Tsuji H; Honma M; Iizuka H
    J Dermatol; 2014 Aug; 41(8):686-9. PubMed ID: 25040258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mental health status, including depression and quality of life among members of an elderly club in suburban Bangkok.
    Kosulwit L
    J Med Assoc Thai; 2012 Jan; 95 Suppl 1():S92-101. PubMed ID: 23964450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between clinical characteristics including presence of exposed lesions and health-related quality of life (HRQoL) in patients with psoriasis: analysis from the nationwide epidemiologic study for psoriasis in Korea (EPI-PSODE study).
    Youn SW; Lee JH; Yu DY; Kim Y; Kim BS; Seo SJ; Choe YB; Yun SK; Park J; Kim NI; Choi CW; Youn JI; Lee SJ; Lee MG; Kim KJ; Park CJ; Ro YS; Song HJ; Shin BS; Ahn SK; Lee JY; Won YH; Jang MS; Kim KH; Kim MH; Kim TY; Choi JH
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1499-1506. PubMed ID: 29430733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cross-sectional study using the Children's Dermatology Life Quality Index (CDLQI) in childhood psoriasis: negative effect on quality of life and moderate correlation of CDLQI with severity scores.
    de Jager ME; van de Kerkhof PC; de Jong EM; Seyger MM
    Br J Dermatol; 2010 Nov; 163(5):1099-101. PubMed ID: 20716218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.